Leisha A Emens

Leisha A Emens

UNVERIFIED PROFILE

Are you Leisha A Emens?   Register this Author

Register author
Leisha A Emens

Leisha A Emens

Publications by authors named "Leisha A Emens"

Are you Leisha A Emens?   Register this Author

89Publications

2349Reads

7Profile Views

Breast cancer vaccines: Heeding the lessons of the past to guide a path forward.

Cancer Treat Rev 2020 Mar 29;84:101947. Epub 2019 Nov 29.

UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2019.101947DOI Listing
March 2020

Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.

J Immunother Cancer 2019 Oct 23;7(1):274. Epub 2019 Oct 23.

School of Medicine, Oncology/Immunology, Johns Hopkins University, The Skip Viragh Outpatient Cancer Building, Floor 8, Viragh 8200-30, Box 11, 201 N Broadway, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0740-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813065PMC
October 2019

Cytokine profiling of tumor-infiltrating T lymphocytes by flow cytometry.

Methods Enzymol 2020 18;631:1-20. Epub 2019 Oct 18.

Department of Medicine, UPMC Hillman Cancer Center, and UPMC Magee Women's Hospital, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.mie.2019.08.015DOI Listing
October 2019

Development of [F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide.

Mol Imaging 2019 Jan-Dec;18:1536012119852189

1 Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1536012119852189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563393PMC
June 2019

The dawn of immunotherapy for breast cancer.

Authors:
Leisha A Emens

Clin Adv Hematol Oncol 2019 Jun;17(6):332-335

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

View Article

Download full-text PDF

Source
June 2019

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply.

N Engl J Med 2019 03;380(10):987-988

University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1900150DOI Listing
March 2019

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

N Engl J Med 2018 11 20;379(22):2108-2121. Epub 2018 Oct 20.

From the Barts Cancer Institute, Queen Mary University of London, London (P.S.); Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.); the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California; University Hospital Heidelberg, Heidelberg, Germany (A.S.); Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil; Aichi Cancer Center Hospital, Nagoya, Japan (H.I.); the Department of Medical Oncology, Institut Curie, Paris (V.D.); Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.); Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.); Roche, Basel, Switzerland (V.H., A.H.); Dana-Farber Cancer Institute, Boston (E.P.W.); Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.); and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1809615
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1809615DOI Listing
November 2018

STING signaling: a key to therapeutic tumor immunity.

Immunotherapy 2018 07;10(9):729-731

Department of Oncology, Bloomberg-Kimmel Institute at Johns Hopkins, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2018-0064
Publisher Site
http://dx.doi.org/10.2217/imt-2018-0064DOI Listing
July 2018

Targeting adenosine for cancer immunotherapy.

J Immunother Cancer 2018 06 18;6(1):57. Epub 2018 Jun 18.

Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney-Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0360-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006764PMC
June 2018

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy.

Hum Gene Ther 2018 05 2;29(5):614-625. Epub 2018 Apr 2.

2 Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2017.080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5930796PMC
May 2018

Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.

Hum Pathol 2018 04 27;74:135-147. Epub 2017 Dec 27.

Bloomberg-Kimmel Institute at Johns Hopkins, Baltimore, MD 21287; Department of Oncology, Johns Hopkins Hospital, Baltimore, MD 21287. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.12.010DOI Listing
April 2018

Breast Cancer Immunotherapy: Facts and Hopes.

Authors:
Leisha A Emens

Clin Cancer Res 2018 02 11;24(3):511-520. Epub 2017 Aug 11.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-3001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796849PMC
February 2018

Report on the Third FDA-AACR Oncology Dose-Finding Workshop.

Cancer Immunol Res 2017 12;5(12):1058-1061

U.S. Food and Drug Administration, Silver Spring, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0590DOI Listing
December 2017

PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast.

Mod Pathol 2017 11 21;30(11):1551-1560. Epub 2017 Jul 21.

Department of Pathology, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.79DOI Listing
November 2017

Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.

Eur J Cancer 2017 08 15;81:116-129. Epub 2017 Jun 15.

Research Branch, Sidra Medical and Research Centre, Doha, Qatar. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.01.035DOI Listing
August 2017

Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo.

Int Immunopharmacol 2017 May 7;46:112-123. Epub 2017 Mar 7.

Johns Hopkins University School of Medicine, Department of Oncology, Baltimore, MD 21287, USA; Johns Hopkins University School of Medicine, Graduate Program in Pathobiology, Baltimore, MD 21287, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2017.02.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811992PMC
May 2017

Specific immunotherapy in ovarian cancer: a systematic review.

Immunotherapy 2016 10;8(10):1193-204

Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0034DOI Listing
October 2016

Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.

Am J Surg Pathol 2016 08;40(8):1090-9

Departments of *Pathology †Oncology ‡Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD §Department of Surgery, Thomas Jefferson University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000674DOI Listing
August 2016

It's TIME for a biomarker-driven approach to cancer immunotherapy.

Authors:
Leisha A Emens

J Immunother Cancer 2016 16;4:43. Epub 2016 Aug 16.

Department of Oncology, Johns Hopkins University School of Medicine, The Kimmel Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building 1, 1650 Orleans Street, Room 409, Baltimore, MD 21231-1000 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0147-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986195PMC
August 2016

Cancer immunotherapy trials: leading a paradigm shift in drug development.

J Immunother Cancer 2016 19;4:42. Epub 2016 Jul 19.

Division of Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0146-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949883PMC
July 2016

Targeting the programmed cell death-1 pathway in breast and ovarian cancer.

Curr Opin Obstet Gynecol 2016 Apr;28(2):142-7

aDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA bThe Netherlands Cancer Institute, Amsterdam, the Netherlands cThe Kelly Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GCO.0000000000000257DOI Listing
April 2016

The immune microenvironment of breast ductal carcinoma in situ.

Mod Pathol 2016 Mar 15;29(3):249-58. Epub 2016 Jan 15.

Department of Oncology, Sidney Kimmel Cancer Center, The Johns Hopkins Hospital, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2015.158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484584PMC
March 2016

Chemotherapy--A Viable Partner for Cancer Immunotherapy?

Authors:
Leisha A Emens

JAMA Oncol 2015 Nov;1(8):1095-7

Kimmel Cancer Center at Johns Hopkins, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.2733DOI Listing
November 2015

Introducing the clinical trials monitor: a new section of the journal for immunotherapy of cancer.

J Immunother Cancer 2015 20;3:49. Epub 2015 Oct 20.

Translational Tumor Immunology Group, Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0092-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617860PMC
October 2015

Emerging immunotherapies in ovarian cancer.

Discov Med 2015 Sep;20(109):97-109

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21202, USA.

View Article

Download full-text PDF

Source
September 2015

Antagonists of PD-1 and PD-L1 in Cancer Treatment.

Semin Oncol 2015 Aug 10;42(4):587-600. Epub 2015 Jun 10.

Department of Surgery, The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.05.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555873PMC
August 2015

Reflex estrogen receptor/progesterone receptor/human epidermal growth factor receptor 2 (ER/PR/Her2) analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs.

Am J Surg Pathol 2015 Jul;39(7):939-47

Departments of *Pathology †Oncology ‡Surgery, The Johns Hopkins Medical Institutions, Baltimore, MD §Department of Surgery, Thomas Jefferson University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000424DOI Listing
July 2015

The interplay of immunotherapy and chemotherapy: harnessing potential synergies.

Cancer Immunol Res 2015 May;3(5):436-43

Cancer Immunology and Immunotherapy Centre, School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom. Department of Medical Oncology, University Hospital Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012642PMC
May 2015

Immune targeting in breast cancer.

Oncology (Williston Park) 2015 May;29(5):375-85

View Article

Download full-text PDF

Source
May 2015

A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.

Cancer Immunol Res 2014 Oct 12;2(10):949-61. Epub 2014 Aug 12.

Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Program in Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211036PMC
October 2014

A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Hum Pathol 2013 Nov 31;44(11):2494-500. Epub 2013 Jul 31.

Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998645PMC
November 2013

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.

Hum Pathol 2013 Oct 21;44(10):2055-63. Epub 2013 May 21.

Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD 21231, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758372PMC
October 2013

HER2-directed therapy for metastatic breast cancer.

Oncology (Williston Park) 2013 Mar;27(3):166-75

Breast Cancer and Tumor Immunology Cancer Research Programs, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
March 2013

Chemoimmunotherapy: reengineering tumor immunity.

Cancer Immunol Immunother 2013 Feb 7;62(2):203-16. Epub 2013 Feb 7.

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1388-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608094PMC
February 2013

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade.

Authors:
Leisha A Emens

Expert Rev Anticancer Ther 2012 Dec;12(12):1597-611

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, 1650 Orleans Street, Room 409, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587160PMC
December 2012

Re-purposing cancer therapeutics for breast cancer immunotherapy.

Authors:
Leisha A Emens

Cancer Immunol Immunother 2012 Aug 28;61(8):1299-305. Epub 2012 Mar 28.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1247-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582212PMC
August 2012

Chemoimmunotherapy.

Authors:
Leisha A Emens

Cancer J 2010 Jul-Aug;16(4):295-303

Department of Oncology, The Johns Hopkins University, 1650 Orleans St, Room 409, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-201007000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e3181eb5066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919833PMC
December 2010

The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages.

Int Immunopharmacol 2010 Oct 15;10(10):1220-8. Epub 2010 Jul 15.

Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2010.07.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949513PMC
October 2010

Postoperative endocrine therapy for invasive breast cancer.

Cancer Treat Res 2009 ;151:139-61

Department of Oncology, The Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-75115-3_10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086398PMC
August 2010

Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.

Cell Immunol 2010 6;263(1):79-87. Epub 2010 Mar 6.

Department of Oncology, Sidney Kimmel Cancer Center, Division of Immunology, Johns Hopkins University, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00088749100006
Publisher Site
http://dx.doi.org/10.1016/j.cellimm.2010.03.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862830PMC
August 2010

GM-CSF-secreting vaccines for solid tumors: moving forward.

Discov Med 2010 Jul;10(50):52-60

Department of Oncology and The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086372PMC
July 2010

GM-CSF-secreting vaccines for solid tumors.

Authors:
Leisha A Emens

Curr Opin Investig Drugs 2009 Dec;10(12):1315-24

The Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, 1650 Orleans Street, Room 409, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
December 2009

Cancer vaccines: on the threshold of success.

Authors:
Leisha A Emens

Expert Opin Emerg Drugs 2008 Jun;13(2):295-308

Johns Hopkins University, Tumor Immunology and Breast Cancer Research Programs, Department of Oncology, 1650 Orleans Street, Room 409, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.13.2.295DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086397PMC
June 2008

Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.

J Clin Invest 2008 May;118(5):1700-11

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 4M86, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI34333DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289797PMC
May 2008

Chemotherapy and tumor immunity: an unexpected collaboration.

Authors:
Leisha A Emens

Front Biosci 2008 Jan 1;13:249-57. Epub 2008 Jan 1.

Department of Oncology, The Johns Hopkins University and the Sidney Kimmel Comprehensive Cancer Center, 1650 Orleans Street, Room 4M90, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086378PMC
http://dx.doi.org/10.2741/2675DOI Listing
January 2008

GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.

Curr Opin Mol Ther 2007 Oct;9(5):490-7

The Johns Hopkins University and the Sidney Kimmel, Comprehensive Cancer Center Department of Oncology, Bunting Blaustein Cancer Research Building, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
October 2007

A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism.

Clin Cancer Res 2007 Jul;13(13):3951-9

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0374DOI Listing
July 2007

Roadmap to a better therapeutic tumor vaccine.

Authors:
Leisha A Emens

Int Rev Immunol 2006 Sep-Dec;25(5-6):415-43

Department of Oncology, Johns Hopkins University and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/08830180600992423DOI Listing
January 2007

Towards a therapeutic breast cancer vaccine: the next steps.

Authors:
Leisha A Emens

Expert Rev Vaccines 2005 Dec;4(6):831-41

Department of Oncology, The Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Room 4M90, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.4.6.831DOI Listing
December 2005

Cancer vaccines in combination with multimodality therapy.

Cancer Treat Res 2005 ;123:227-45

The Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Room 4M90 Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/0-387-27545-2_10DOI Listing
November 2005

Leveraging the activity of tumor vaccines with cytotoxic chemotherapy.

Cancer Res 2005 Sep;65(18):8059-64

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1797DOI Listing
September 2005

Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer.

Authors:
Leisha A Emens

Am J Ther 2005 May-Jun;12(3):243-53

Tumor Immunology and Breast Cancer Research Programs, Sidney Kimmel Comprehensive Cancer Center, Baltimore 21231-1000, Maryland, USA.

View Article

Download full-text PDF

Source
August 2005

Augmenting the potency of breast cancer vaccines: combined modality immunotherapy.

Breast Dis 2004 ;20:13-24

Department of Oncology, The Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/bd-2004-20103DOI Listing
April 2005

Trastuzumab in breast cancer.

Oncology (Williston Park) 2004 Aug;18(9):1117-28; discussion 1131-2, 1137-8

Breast Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins University School of Medicine Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
August 2004

Cancer vaccines: an old idea comes of age.

Cancer Biol Ther 2003 Jul-Aug;2(4 Suppl 1):S161-8

Departments of Oncology, The Sidney Kimmel Comprehensive Cancer Center; Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
February 2004

Survivin' cancer.

Authors:
Leisha A Emens

Cancer Biol Ther 2004 Feb 1;3(2):180-3. Epub 2004 Feb 1.

The Sidney Kimmel Comprehensive Cancer Center, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Room 4M90, Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.3.2.751DOI Listing
February 2004

A new twist on autologous cancer vaccines.

Authors:
Leisha A Emens

Cancer Biol Ther 2003 Mar-Apr;2(2):161-3

The Sidney Kimmel Comprehensive Cancer Center, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Room 4M90, Baltimore, Maryland 21231-1000 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.2.2.283DOI Listing
October 2003

Toward a breast cancer vaccine: work in progress.

Oncology (Williston Park) 2003 Sep;17(9):1200-11; discussion 1214, 1217-8

Sidney Kimmel, Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
September 2003

To live or not to live: that depends on GAGE?

Cancer Biol Ther 2002 Jul-Aug;1(4):388-90

Departments of Oncology, The Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
July 2003

The follow-up of breast cancer.

Semin Oncol 2003 Jun;30(3):338-48

Department of Oncology, The Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0093-7754(03)00094-0DOI Listing
June 2003

Cytokine gene-modified cell-based cancer vaccines.

Methods Mol Med 2002 ;69:233-57

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-141-8:233DOI Listing
January 2003

Adjuvant hormonal therapy for premenopausal women with breast cancer.

Clin Cancer Res 2003 Jan;9(1 Pt 2):486S-94S

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231-1000, USA.

View Article

Download full-text PDF

Source
January 2003

Regression of splenic lymphoma after treatment of hepatitis C virus infection.

N Engl J Med 2002 Dec;347(26):2168-70; author reply 2168-70

View Article

Download full-text PDF

Source
December 2002